What is the recommended diagnostic workup and treatment plan for hyperthyroidism in a non‑pregnant adult?

Hyperthyroidism: Diagnostic Workup and Treatment in Non-Pregnant Adults

Initial Diagnostic Workup

Confirm biochemical hyperthyroidism with serum TSH (suppressed) and free T4 and/or T3 (elevated), then establish the etiology using TSH-receptor antibodies, thyroid peroxidase antibodies, and thyroid ultrasound, reserving thyroid scintigraphy for cases with nodules or unclear etiology. 1, 2

Biochemical Confirmation

• Measure serum TSH first—suppressed TSH (<0.1 mIU/L for overt disease) with elevated free T4 and/or T3 confirms overt hyperthyroidism 1, 2
• Subclinical hyperthyroidism shows low TSH with normal free T4 and T3 levels 1, 3

Etiological Diagnosis

• Graves disease (70% of cases): Check TSH-receptor antibodies (positive in Graves), look for diffuse goiter, exophthalmos, or thyroid eye disease on examination 1, 2, 4
• Toxic nodular goiter (16% of cases): Palpable nodules, symptoms of neck compression (dysphagia, orthopnea, voice changes) 1, 2
• Thyroiditis (3% of cases): Transient thyrotoxicosis, often painless 2, 5
• Drug-induced (9% of cases): History of amiodarone, tyrosine kinase inhibitors, or immune checkpoint inhibitors 2

Imaging Studies

• Thyroid ultrasound with color Doppler: Assess vascularity (hypervascularity in Graves), nodules, and gland size 4, 6
• Thyroid scintigraphy with technetium-99m or radioactive iodine: Use when nodules are present or etiology remains unclear after initial workup 1, 6

---

Treatment Plan for Overt Hyperthyroidism

For Graves disease, initiate methimazole 12-18 months as first-line therapy; for toxic nodular goiter, proceed directly to radioactive iodine ablation or thyroidectomy as definitive treatment. 2, 5, 4

Graves Disease Treatment Algorithm

First-Line: Antithyroid Drugs (12-18 months)

• Methimazole is preferred over propylthiouracil due to better safety profile 5, 4
• Standard course: 12-18 months, then reassess TSH-receptor antibodies 4
• Recurrence risk ~50% after stopping antithyroid drugs 2
• High-risk features for recurrence: age <40 years, free T4 ≥40 pmol/L, TSH-binding inhibitory immunoglobulins >6 U/L, goiter ≥WHO grade 2 2

Options After Initial Course

• If TSH-receptor antibodies remain high at 12-18 months: Continue methimazole for another 12 months or proceed to definitive treatment 4
• Long-term methimazole (5-10 years): Reduces recurrence to ~15% versus 50% with short-term treatment; viable alternative to definitive therapy 2, 7
• If relapse occurs: Definitive treatment (radioactive iodine or thyroidectomy) is recommended, though long-term low-dose methimazole is acceptable 4

Definitive Treatment Options

• Radioactive iodine ablation: Most widely used treatment in the United States 5

  • Contraindicated in active/severe thyroid eye disease 4, 8
  • Requires steroid prophylaxis (short course low-dose prednisone) if mild/active thyroid eye disease present 4, 8

• Total thyroidectomy: Performed by high-volume thyroid surgeon 4

  • Preferred when large goiter, compressive symptoms, or patient preference 2, 5
  • Does not worsen thyroid eye disease 8

Toxic Nodular Goiter Treatment

• Radioactive iodine ablation or thyroidectomy are primary treatments 2, 5
• Antithyroid drugs rarely used except for temporary control 2
• Radiofrequency ablation is emerging but not standard 2

Thyroiditis Management

• Observation with supportive care for mild cases 1, 5
• Beta-blockers for symptomatic relief (palpitations, tremor, anxiety) 5
• Steroids only for severe cases 2
• Self-limited condition; thyroid hormone synthesis not increased 5

---

Treatment of Subclinical Hyperthyroidism

Treat subclinical hyperthyroidism (TSH <0.1 mIU/L) in patients >65 years or those with cardiovascular disease or osteoporosis risk, as this degree of TSH suppression increases risk of atrial fibrillation, bone loss, and cardiovascular mortality. 1, 7, 3

Treatment Indications

• **TSH persistently <0.1 mIU/L**: Highest risk group, treatment recommended especially if age >65 years 1, 7
• Associated with atrial fibrillation, osteoporosis, fractures, dementia, and increased cardiovascular mortality 7, 3
• Randomized trial data show TSH normalization decreases atrial fibrillation risk 3

Treatment Approach

• Long-term low-dose methimazole is effective and safe in older adults 7
• Same definitive options (radioactive iodine, thyroidectomy) available as for overt disease 1

---

Special Considerations and Pitfalls

Thyroid Eye Disease Complications

• Mild thyroid eye disease: Any treatment acceptable, but use steroid prophylaxis if radioactive iodine selected and disease is recent-onset 8
• Moderate-to-severe active disease: Antithyroid drugs or thyroidectomy preferred; avoid radioactive iodine 8
• Sight-threatening disease: Control hyperthyroidism with antithyroid drugs while prioritizing aggressive thyroid eye disease treatment 8

Older Adults (>65 years)

• Both overt hypothyroidism and hyperthyroidism require treatment due to significant cardiovascular risk 7
• Avoid over- and under-replacement with thyroid hormone, as both associate with adverse cardiovascular and skeletal events 7
• Maintain euthyroidism carefully given comorbidities and polypharmacy 7

Monitoring During Treatment

• Rapid and sustained control of hyperthyroidism improves prognosis and may reduce mortality 2
• TSH-receptor antibodies should be measured before stopping antithyroid drugs to assess recurrence risk 4
• Regular thyroid function monitoring essential to avoid iatrogenic hypothyroidism 4